STOCK TITAN

CEL-SCI (CVM) CFO awarded 1,336 Common Stock shares in Form 4 filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

PRICHEP PATRICIA B reported acquisition or exercise transactions in this Form 4 filing.

CEL-SCI Corp Chief Financial Officer Patricia B. Prichep received a grant of 1,336 shares of Common Stock on March 31, 2026. The grant is recorded at $3.21 per share and brings her direct holdings to 13,364 shares, reflecting a routine compensation-related equity award.

Positive

  • None.

Negative

  • None.
Insider PRICHEP PATRICIA B
Role Chief Financial Officer
Type Security Shares Price Value
Grant/Award Common Stock 1,336 $3.21 $4K
Holdings After Transaction: Common Stock — 13,364 shares (Direct)
Footnotes (1)
Shares granted 1,336 shares Common Stock grant on March 31, 2026
Grant price $3.21 per share Recorded value for the equity award
Total shares after 13,364 shares Direct holdings following the grant
Common Stock financial
"security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
PRICHEP PATRICIA B

(Last)(First)(Middle)
8229 BOONE BLVD., SUITE 802

(Street)
VIENNA VIRGINIA 22182

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
CEL SCI CORP [ CVM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock03/31/2026A1,336A$3.2113,364D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
Patricia Prichep04/01/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did CEL-SCI Corp (CVM) report for Patricia B. Prichep?

CEL-SCI Corp reported that CFO Patricia B. Prichep received a grant of 1,336 Common Stock shares. The award was recorded at $3.21 per share and is categorized as a grant, award, or other acquisition on a Form 4 insider filing.

How many CEL-SCI Corp (CVM) shares does the CFO hold after this Form 4 grant?

After the reported grant, CEL-SCI Corp’s CFO Patricia B. Prichep directly holds 13,364 Common Stock shares. This total incorporates the 1,336-share equity award reported, indicating her updated ownership position following the March 31, 2026 transaction.

Was the CEL-SCI Corp (CVM) CFO’s Form 4 transaction a purchase or a grant?

The Form 4 transaction for CEL-SCI Corp’s CFO was a grant or award, not an open-market purchase. It is classified under code A as a grant, award, or other acquisition, reflecting compensation-related share issuance rather than a typical market buy.

What was the price used for the CEL-SCI Corp (CVM) CFO share grant?

The CFO’s 1,336-share grant of CEL-SCI Corp Common Stock was recorded at $3.21 per share. This price is the transaction value used in the Form 4 filing, providing a reference amount for the equity award on March 31, 2026.

Does the CEL-SCI Corp (CVM) Form 4 show direct or indirect ownership for the CFO?

The Form 4 indicates that CEL-SCI Corp’s CFO holds the reported shares as direct ownership. The filing marks the ownership type as direct, meaning the 13,364 Common Stock shares are attributed directly to Patricia B. Prichep rather than through another entity.
CEL-SCI Corp

NYSE:CVM

View CVM Stock Overview

CVM Rankings

CVM Latest News

CVM Latest SEC Filings

CVM Stock Data

27.15M
7.77M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
VIENNA